Answer
Each Lunsumio (mosunetuzumab) intravenous infusion during the first treatment cycle should be administered over at least 4 hours, never as an intravenous push or bolus.
Sources for this answer
- Lunsumio 1 mg and 30 mg concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.2 Posology and method of administration · Version 11Document updated
Sources checked